Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 17 studies | 33% ± 12% | |
lung | 13 studies | 29% ± 13% | |
kidney | 8 studies | 31% ± 13% | |
brain | 6 studies | 24% ± 8% | |
liver | 5 studies | 31% ± 12% | |
bone marrow | 4 studies | 26% ± 6% | |
intestine | 4 studies | 25% ± 5% | |
pancreas | 3 studies | 20% ± 3% | |
placenta | 3 studies | 25% ± 8% | |
thymus | 3 studies | 40% ± 18% | |
adipose | 3 studies | 27% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 6273.52 | 89 / 89 | 100% | 46.88 | 898 / 901 |
liver | 100% | 3609.26 | 226 / 226 | 96% | 21.94 | 391 / 406 |
stomach | 96% | 1386.33 | 343 / 359 | 100% | 18.07 | 285 / 286 |
lung | 100% | 3530.06 | 577 / 578 | 94% | 15.86 | 1082 / 1155 |
adrenal gland | 100% | 4068.65 | 258 / 258 | 93% | 22.08 | 214 / 230 |
intestine | 93% | 1794.73 | 897 / 966 | 98% | 21.98 | 519 / 527 |
breast | 94% | 1607.86 | 432 / 459 | 97% | 17.48 | 1079 / 1118 |
prostate | 97% | 1486.07 | 237 / 245 | 87% | 8.57 | 438 / 502 |
brain | 82% | 1499.52 | 2168 / 2642 | 94% | 13.91 | 664 / 705 |
bladder | 90% | 1210.19 | 19 / 21 | 85% | 15.63 | 427 / 504 |
thymus | 79% | 878.15 | 516 / 653 | 94% | 12.61 | 571 / 605 |
skin | 92% | 1957.42 | 1667 / 1809 | 74% | 7.56 | 350 / 472 |
esophagus | 64% | 693.71 | 930 / 1445 | 84% | 10.61 | 154 / 183 |
uterus | 47% | 417.78 | 80 / 170 | 86% | 11.04 | 397 / 459 |
pancreas | 18% | 130.31 | 60 / 328 | 96% | 14.00 | 171 / 178 |
ovary | 41% | 342.36 | 73 / 180 | 68% | 5.35 | 292 / 430 |
lymph node | 0% | 0 | 0 / 0 | 100% | 32.45 | 29 / 29 |
spleen | 100% | 3176.05 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.05 | 1 / 1 |
muscle | 100% | 17148.24 | 800 / 803 | 0% | 0 | 0 / 0 |
adipose | 100% | 2420.63 | 1199 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 4195.55 | 905 / 929 | 0% | 0 | 0 / 0 |
heart | 95% | 2586.26 | 817 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 95% | 2413.50 | 1263 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 9.01 | 40 / 45 |
eye | 0% | 0 | 0 / 0 | 6% | 0.41 | 5 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045838 | Biological process | positive regulation of membrane potential |
GO_0015949 | Biological process | nucleobase-containing small molecule interconversion |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0017080 | Molecular function | sodium channel regulator activity |
GO_0005515 | Molecular function | protein binding |
GO_0015038 | Molecular function | glutathione disulfide oxidoreductase activity |
Gene name | GLRX |
Protein name | Glutaredoxin-1 (Thioltransferase-1) (TTase-1) |
Synonyms | GRX |
Description | FUNCTION: Has a glutathione-disulfide oxidoreductase activity in the presence of NADPH and glutathione reductase. Reduces low molecular weight disulfides and proteins. |
Accessions | ENST00000508780.5 P35754 ENST00000237858.11 ENST00000379979.8 ENST00000512469.2 ENST00000505427.1 |